| 摘要 |
The invention relates to an accurate computer-based method (the "Method"), related algorithms and apparatus to help diabetic individuals achieve near euglycemic blood glucose levels, as recommend based on Diabetes Control and Complications Trial (DCCT), and in general to help physicians and medical practitioners to devise a dynamic and interactive drug regimen to manage and control various medical conditions and illness. The method uses artificial intelligence to learn about the drug behavior and assimilation for each individual and devises an ideal drug regiment for each such individual, according to the individual's lifestyle and medicals needs. When applied to management of diabetes, the Method achieves the DCCT goals despite diet variations, meal times and other day-to-day changes, with minimum number of injections. |
